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EDITORIAL

Challenges of Pediatric Disease in Adulthood
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E

lsewhere in this issue of the Journal of PatientCentered Research and Reviews, Doyle and
colleagues explore functional outcomes
and lived experiences of adults with X-linked
hypophosphatemia.1 This entity, generally diagnosed
in the pediatric age group, progresses in adulthood
with increasing pain and disability. The study authors
identified 3 primary themes common to their patient
population: presence of chronic pain, fear of falling,
and perception of lack of clinician credence given to
patient concerns.1 The traits of resistance, adaptability,
and compensation among patients with X-linked
hypophosphatemia also were noted.1

In this editorial, 4 other known medical and surgical
conditions have been chosen as examples to illustrate
the issues often faced by adults with childhood-onset
disease. In all cases, the transition from pediatric
to adult care has the potential to produce (at least
transiently) lower physical and psychological wellbeing than at pretransition, and issues may vary by
gender and the specific medical condition.7 Certainly,
very individualized experiences of transition are to be
anticipated.

There are many well-described childhood-onset
diseases that remain problematic for adults and cause
significant physical and psychological morbidity —
type 1 diabetes mellitus,3 sickle cell disease,4 autism,5
and pediatric age-onset liver disease,6 to name a few.

Down Syndrome
We will discuss and primarily focus on Down syndrome
(DS) as a prototype condition in this regard. In the
past, individuals with DS less frequently lived into
adulthood, but that number has increased significantly
since the early 1980s, when life expectancy was about
25 years, to about 60 years now.8-10 People with Down
syndrome often have difficulty finding health care
providers who can or will provide services for adults.
The reasons include: 1) concerns regarding inadequate
insurance reimbursement (particularly Medicaid),
which may be particularly problematic due to longer
time often needed for appointments; and 2) clinician’s
lack of knowledge, as there is often insufficient
training in caring for adults with DS in medical school
and residency.cf.11 An additional challenge for adults
with DS is finding a provider who will communicate
directly with the individual with DS and will include
them (to the level of the patient’s capability) in health
care decision-making.
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Particular medical issues facing adults with DS can be
placed broadly (with some overlap) into 3 categories:
DS-associated diseases that occur in childhood or
adolescence and persist into adulthood; DS-associated
diseases that tend to first manifest in adulthood;

We have previously reported on the issue of transitions
of care from the pediatric to the adult clinical world
among patients with significant childhood-onset
disease.2 That focused review explored the current
status of such health care transitions, the logistics and
pitfalls of these transitions, and measures that practices
and health care systems could take to ensure more
effective care.2 This commentary further discusses the
medical pitfalls and psychosocial issues surrounding
childhood-onset disease in adult survivors once
transition has taken place.
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and common adult comorbidities that may arise
independent of, or are partially associated with, DS
(diabetes mellitus, dyslipidemia, etc).8,9,12
Congenital heart disease (CHD) is one example in the
first category. Approximately half of patients with DS
have CHD, most commonly endocardial cushion and
ventricular septal defects.12,13 Many of these defects
are repaired prior to adulthood; however, patients
with DS are at higher risk of acquired valvular
and other heart disease, which may not manifest
until adulthood.12 There is a higher risk of embolic
(presumed to be related to congenital heart disease)
and hemorrhagic stroke in adults with DS.14 Similarly,
orthopedic problems, and the much less common
congenital defects of the gastrointestinal tract, also
may be discovered and repaired prior to adulthood;
celiac disease has a higher prevalence in DS and may
first become recognized in adulthood.8,9,12,13
Constipation, obesity, hearing loss, and diseases from
narrowed otolaryngologic passage (ie, congestion,
cerumenosis, obstructive sleep apnea) as well as
immune system, hematologic, and ophthalmologic
problems are examples of issues that typically carry
across the life span.8,9,12,13,15,16 Seizures in DS have a
trimodal distribution, with the second peak occurring
after puberty.9 Thyroid disease (most typically
hypothyroidism) and osteopenia/osteoporosis may first
manifest in those with DS in childhood or adulthood.8,9,12
A common example in the second category of medical
issues is development of dementia. One community
survey revealed that dementia was associated with
mortality in the majority (70%) of older adults
with DS.17 Virtually all patients with DS will
manifest neuropathological changes consistent with
Alzheimer’s disease, and most will manifest clinical/
symptomatic Alzheimer’s in older age, typically
well before the median age of onset in the general
adult population.18,19 The diagnosis of Alzheimer’s
dementia may be difficult in this population due to
baseline cognitive and behavioral function or clinical
ascertainment of baseline functioning. The ability
of the primary care clinician to follow patients with
DS over a long period of time is helpful in the latter
regard.18 Much investigative work remains to be done
regarding useful tests for early diagnosis, prevention,
and treatment.18,20
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There are gaps in our knowledge about most cooccurring conditions in adults with DS. Many cooccurring conditions have a different incidence profile.
This can lead to over- and underdiagnosis. In addition,
we do not have clear direction on how we should
alter screening and prevention recommendations.
Atherosclerosis is very uncommon, for example, as
are solid tumors.8,14 Should we be screening for certain
cancers (eg, colonoscopy, mammogram) or treating
patients with statins to lower the risk of myocardial
infarctions (that are uncommon)?8,21 Other conditions
are more common — what are screening implications
for Alzheimer’s, sleep apnea, thyroid disease and
others? There are also gaps in our knowledge in how
best to include people with DS in their own health
promotion. The problem is not that people with DS
cannot learn how to participate in promoting their
health (most individuals can), the problem is that we
have not figured out the best ways to include them in
the process.
Particular pitfalls to avoid for clinicians taking care
of adult patients with DS include missing physical,
sexual, or psychological abuse, failure to provide
routine adult preventive care, overevaluation or
overtreatment of minor hematologic and other
laboratory “abnormalities” that may be typical of DS,
delayed diagnosis of emerging disorders such as sleep
apnea, leukemia, and early onset Alzheimer’s, and
failure to address palliative and end-of-life care at the
appropriate time.8,9,15,22
A significant problem faced by adults with DS is the
lack of understanding by providers of the interaction
between mental and physical health.23,24 Particularly
when the individual has limited verbal skills, the
likelihood that the presentation of the physical problem
will be wholly or partially behavioral in etiology or the
result of a change in their mental health is significant.
This lack of knowledge may lead to inadequate
or inaccurate treatment, often overdiagnosis of
mental health problems without appreciation of the
contribution of physical health. Some psychiatric-like
presentations are manifestations of acute regression,
which may be triggered by a significant emotional
stress.24,25 Similarly, there is overdiagnosis of mental
health problems due to the lack of understanding
of common characteristics of people with DS. For
example, a very high percentage of people with DS talk
www.aurora.org/jpcrr
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to themselves (“self-talk”). This is often misinterpreted
as psychoses and can lead to overtreatment.23,26
Social issues are significant, and the following
examples only scratch the surface. For many children
with DS who transition to adulthood and graduate from
the school system, there are significant challenges
in finding employment and meaningful activity.27
Finding appropriate residential opportunities is also a
significant challenge for many. These have significant
implications for physical and mental health. In older
adults, the earlier onset of some health conditions,
particularly Alzheimer’s, presents additional
challenges. This is often complicated by the primary
caregiver being an aging parent(s). Both authors of
this editorial have observed the unique situation for
siblings in which both the parent and the sibling with
DS develop Alzheimer’s at the same time.
Cystic Fibrosis
In developed countries, the majority of patients with
cystic fibrosis (CF) live into adulthood.28,29 This has
resulted in the need for infrastructure to ensure a
workforce of respiratory care clinicians and support
staff who are adequately trained in the management of
CF in adults.28,29 Primary care clinics also need to be
attuned to the nuances of care for this population29 and
where to best access referral services, including lung
transplant teams, if needed.
Medically, major life-threatening presentations in
adult patients with CF include respiratory infections,
pneumothorax, respiratory failure, and gross
hemoptysis.28 Nonthreatening but important issues
include the potential for additional morbidity (eg,
diabetes), substance abuse, liver disease, and other
adult medical problems.28 Some clinical paradigms are
changing with regard to adult CF care; for example,
a decline in the prevalence of traditional CF airway
pathogens has been observed.30
Major psychosocial issues facing adults with
CF include having normal family and friend
relationships, employment barriers (including the
need for additional time to complete assignments and
illness-day accommodations), coping with complex
medical needs and treatments, depression, anxiety,
and uncertainty and distress regarding early death.28,31
Other issues cross over between the psychosocial
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and the medical realm, including concealment of
disease, reproductive challenges, and adherence
to treatment.28,31 Screening for and attention to
socially complex young adults with CF at the time of
transition to adult care may result in fewer avoidable
hospitalizations.32
Fortunately, in the case of CF, there are now many
facilities for adult CF care in the United States, and
transition from pediatric providers generally occurs
without significant gaps in care.33 That said, major
complications and premature death remain prevalent.
Attention must be paid to proper palliative and end-oflife care.28,34
Congenital Heart Disease
Once associated with a grim prognosis, most patients
with CHD undergo successful neonatal cardiac surgery
and survive into adulthood.35,36 One author made the
point that these individuals “are not ‘cured’ and almost
all require lifelong cardiac care.”35 While limited adult
life span may be a central issue for patients with CF,
some adults with CHD also still deal with “threatened
futures.”31 Like all examples discussed in this editorial,
a primary care medical home and coordination with
specialists is paramount for CHD management, and
issues of lifestyle, prevention, and psychosocial care
remain important.2,31,35
Significant medical/surgical issues remain for many
adults with CHD, including risk of reoperation, heart
failure, need for heart transplantation, complications
like atrial fibrillation, and premature death.36 Increased
risk of premature death is particularly associated
with the following CHD patient groups: those having
had cyanotic heart disease (especially those with
Eisenmenger syndrome [development of pulmonary
hypertension leading to shunt reversal and cyanosis]);
those with repaired tetralogy of Fallot; those with
Fontan palliation procedures for single ventricle; and
those with subaortic right ventricles.36
Currently, a number of percutaneous and other less
invasive techniques for cardiac repair in adults with
CHD are increasingly being used.37 While this has
decreased the number of more invasive surgeries, and
increased the quality of life for these patients, longterm outcomes need to be studied.37
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Hirschsprung Disease
Lastly, the rare congenital condition Hirschsprung disease
is generally surgically repaired during the first year of
life, and most patients are diagnosed and repaired prior to
young adulthood.38 Despite successful repair, significant
issues remain for adults who had been treated for this
condition as children. This includes constipation, fecal
or urinary incontinence, repeat surgery, and issues of
sexual function.38,39 A study of 66 adults with repaired
Hirschsprung disease in France observed reports of
significant emotional distress and concerns regarding body
image, but higher educational levels and similar marital
and parental status, as those of the general population.38
While sexual function is generally preserved in adults with
Hirschsprung disease, sexual distress was a significant
issue in adult women and associated with perceived selfcompetence as an adolescent.39 Hirschsprung disease has
been a significant challenge for patients with DS regarding
limitations on their independence due to incontinence.40
Improving Clinical Support
What can we, as clinicians and caregivers, do to help
this population? First, we must appreciate the blessing
of these individuals living well into adulthood and
frequently thriving. Beyond that, we must ensure that
there is an adequately trained workforce to care for
these adult survivors of serious congenital disease.
In some cases, traditional pediatric specialists have
been extending their care of these specific populations
within their practice well into adulthood.41
We must strive to provide appropriate, thoughtful,
and informed care of common adult conditions that
may have their onset in childhood. This includes
promotion of self-management of health conditions,
when appropriate.7 In addition, we should be attuned
to “normal abnormal” laboratory findings in such
individuals, as those with DS, in addition to unique
adult-onset illnesses such as early Alzheimer’s dementia.
We must be prepared to provide or refer for appropriate
palliative and end-of-life care when the need arises.
Equally important, we need to strive to ensure adequate
psychosocial support for these individuals beyond that
needed for typical adolescent-to-adult transition.7,38
This includes social services and community-based
programs and resources as needed, screening for
abusive situations, and, particularly in the case of CF,
psychological support regarding patients’ concerns
Editorial

surrounding a limited life span.31 We must inquire of the
patient and/or caregivers regarding perceived stigma
due to the patient’s intellectual or physical disabilities
and provide appropriate support.42 Advocacy for the
patient regarding appropriate work and adult education
accommodations is important as well.43
As always, we should be the caring, competent, and
compassionate caregivers that this population deserves.
Note Added in Proof

The authors are reflecting on the suffering likely endured by
adults with Down syndrome and others with cognitive and
physical disabilities during this COVID-19 pandemic. Their
isolation may be particularly acute. Day programs, work
programs, Special Olympics, and other socially enriching
activities are suspended. Grocery store “adventures” may
not be done safely. Technology-based social networking
from home may be severely restricted due to inherent lack of
ability to communicate using these media or older parents not
having such technologies in their homes. Some individuals
may not have the cognitive ability to understand technical/
logistical aspects of social distancing and mask wearing. They
may be scared and confused. For those being hospitalized for
COVID-19, this may be the first frightening experience ever
of not having a parent or personal caregiver at their side. These
patients need our particular attention during these times.

References
1.

2.

3.
4.

5.
6.
7.

8.

Hughes M, Macica C, Meriano C, Doyle M. Giving credence
to the experience of X-linked hypophosphatemia in adulthood:
an interprofessional mixed-methods study. J Patient Cent Res
Rev. 2020;7:176-88.
Mubanga N, Baumgardner DJ, Kram JJF. Health care
transitions for adolescents and young adults with special
health care needs: Where are we now? J Patient Cent Res Rev.
2017;4:90-5. CrossRef
Whittemore R, Delvy R, McCarthy MM. The experience of
partners of adults with type 1 diabetes: an integrated review.
Curr Diabetes Rep. 2018;18:19. CrossRef
de Montalembert M, Guitton C; French Reference Centre for
Sickle Cell Disease. Transition from paediatric to adult care for
patients with sickle cell disease. Br J Haematol. 2014;164:630-5.
CrossRef
Nicolaidis C, Kripke CC, Raymaker D. Primary care for adults
on the autism spectrum. Med Clin North Am. 2014;98:1169-91.
CrossRef
Vajro P, Ferrante L, Lenta S, Mandato C, Persico M. Management
of adults with paediatric-onset chronic liver disease: strategic issues
for transition care. Dig Liver Dis. 2014;46:295-301. CrossRef
While AE, Heery E, Sheehan AM, Coyne I. Health-related
quality of life of young people with long-term illnesses before
and after transfer from child to adult health care. Child Care
Health Dev. 2016;43:144-51. CrossRef
Capone GT, Chicoine B, Bulova P, et al. Co-occurring medical
conditions in adults with Down syndrome: a systematic review
toward the development of health care guidelines. Am J Med
Genet A. 2018;176:116-33. CrossRef
www.aurora.org/jpcrr

145

9.
10.

11.
12.
13.

14.

15.
16.
17.
18.
19.
20.

21.

22.

23.
24.

25.
26.

Ross WT, Olsen M. Care of the adult patient with Down
syndrome. South Med J. 2014;107:715-21. CrossRef
Global Down Syndrome Foundation. Facts and FAQ about
Down
syndrome.
https://www.globaldownsyndrome.
org/about-down-syndrome/facts-about-down-syndrome/
Accessed February 6, 2020.
Ervin DA, Hennen B, Merrick J, Morad M. Healthcare for
persons with intellectual and developmental disability in the
community. Front Public Health. 2014;2:83. CrossRef
Davidson MA. Primary care for children and adolescents with
Down syndrome. Pediatr Clin North Am. 2008;55:1099-111.
CrossRef
Baum RA, Nash PL, Foster JE, Spader M, Ratliff-Schaub K,
Coury DL. Primary care of children and adolescents with Down
syndrome: an update. Curr Probl Pediatr Adolesc Health Care.
2008;38:241-61. CrossRef
Sobey CG, Judkins CP, Sundararajan V, Phan TG, Drummond
GR, Srikanth VK. Risk of major cardiovascular events in people
with Down syndrome. PLoS One. 2015;10(9):e0137093.
CrossRef
Lal C, White DR, Joseph JE, van Bakergem K, LaRosa
A. Sleep-disordered breathing in Down syndrome. Chest.
2015;147:570-9. CrossRef
Mixter S, Stewart RW. Adult head and neck health care needs
for individuals with complex chronic conditions of childhood.
Med Clin North Am. 2018;102:1055-61. CrossRef
Hithersay R, Startin CM, Hamburg S, et al. Association of
dementia with mortality among adults with Down syndrome
older than 35 years. JAMA Neurol. 2019;76:152-60. CrossRef
Nieuwenhuis-Mark RE. Diagnosing Alzheimer’s dementia in
Down syndrome: problems and possible solutions. Res Dev
Disabil. 2009;30:827-38. CrossRef
Salehi A, Ashford JW, Mufson EJ. The link between
Alzheimer’s disease and Down syndrome. A historical
perspective. Curr Alzheimer Res. 2016;13:2-6. CrossRef
Castro P, Zaman S, Holland A. Alzheimer’s disease in people
with Down’s syndrome: the prospects for and the challenges of
developing preventive treatments. J Neurol. 2017;264:804-13.
CrossRef
Alagoz O, Hajjar A, Chootipongchaivat S, et al. Benefits and
harms of mammography screening for women with Down
syndrome: a collaborative modeling study. J Gen Intern Med.
2019;34:2374-81. CrossRef
Saghazadeh A, Mahmoudi M, Dehghani Ashkezari A, Oliaie
Rezaie N, Rezaei N. Systematic review and meta-analysis
shows a specific micronutrient profile in people with Down
Syndrome: lower blood calcium, selenium and zinc, higher red
blood cell copper and zinc, and higher salivary calcium and
sodium. PLoS One. 2017;12(4):e0175437. CrossRef
Smith DS. Health care management of adults with Down
syndrome. Am Fam Physician. 2001;64:1031-8.
Chicoine B, Capone G. Regression in adolescents and adults
with Down syndrome. In: Prasher VP, Janicki MP (eds).
Physical Health of Adults with Intellectual and Developmental
Disabilities, Second Edition. Basel, Switzerland: Springer
Nature Switzerland AG, 2019, pp. 121-40. CrossRef
Mircher C, Cieuta-Walti C, Marey I, et al. Acute regression in
young people with Down syndrome. Brain Sci. 2017;7(6):57.
CrossRef
McGuire D, Chicoine BA, Greenbaum E. “Self-talk” in adults
with Down syndrome. Disability Solutions. 1997;2(2):1, 3-5.

146 JPCRR • Volume 7, Issue 2 • Spring 2020

27. Kumin L, Schoenbrodt L. Employment in adults with Down
syndrome in the United States: results from a national survey.
J Appl Res Intellect Disabil. 2016;29:330-45. CrossRef
28. Elborn JS, Bell SC, Madge SL, et al. Report of the European
Respiratory Society/European Cystic Fibrosis Society task
force on the care of adults with cystic fibrosis. Eur Resp J.
2016;47:420-8.
29. Flume PA. Smoothing the transition from pediatric to adult
care: lessons learned. Curr Opin Pulm Med. 2009;15:611-4.
CrossRef
30. Ramsay KA, Sandhu H, Geake JB, et al. The changing
prevalence of pulmonary infection in adults with cystic fibrosis:
a longitudinal analysis. J Cyst Fibros. 2017;16:70-7. CrossRef
31. Moola FJ, Norman ME. ‘Down the rabbit hole’: enhancing the
transition process for youth with cystic fibrosis and congenital
heart disease by re-imagining the future and time. Child Care
Health Dev. 2011;37:841-51. CrossRef
32. Crowley EM, Bosslet GT, Khan B, Ciccarelli M, Brown CD.
Impact of social complexity on outcomes in cystic fibrosis
after transfer to adult care. Pediatr Pulmonol. 2018;53:735-40.
CrossRef
33. Sawicki GS, Ostrenga J, Petren K, et al. Risk factors for
gaps in care during transfer from pediatric to adult cystic
fibrosis programs in the United States. Ann Am Thorac Soc.
2018;15:234-40. CrossRef
34. Philip JA, Gold M, Sutherland S, et al. End-of-life care in adults
with cystic fibrosis. J Palliat Med. 2008;11:198-203. CrossRef
35. Cotts TB. Transitions of care in congenital disease: allaying
fears for patients and specialists. Prog Cardiovasc Dis.
2018;61:282-6. CrossRef
36. Greutmann M, Tobler D. Changing epidemiology and mortality
in adult congenital heart disease: looking into the future. Future
Cardiol. 2012;8:171-2. CrossRef
37. Wilson W, Osten M, Benson L, Horlick E. Evolving trends in
interventional cardiology: endovascular options for congenital
disease in adults. Can J Cardiol. 2014;30:75-86. CrossRef
38. Drissi F, Meurette G, Baayen C, et al. Long-term outcome
of Hirschsprung disease: impact on quality of life and social
condition at adult age. Dis Colon Rectum. 2019;62:727-32.
CrossRef
39. Witvliet MJ, van Gasteren S, van den Hondel D, Hartman E,
van Heurn L, van der Steeg A. Predicting sexual problems in
young adults with an anorectal malformation or Hirschsprung
disease. J Pediatr Surg. 2018;53:1555-9. CrossRef
40. Friedmacher F, Puri P. Hirschsprung’s disease associated with
Down syndrome: a meta-analysis of incidence, functional
outcomes and mortality. Pediatr Surg Int. 2013;29:937-46.
CrossRef
41. Durkin ET, Zurakowski D, Rangel SJ, Lillehei CW, Fishman
LN. Passing the baton: the pediatric surgical perspective on
transition. J Pediatr Surg. 2015;50:1196-200. CrossRef
42. Ali A, Hassiotis A, Strydom A, King M. Self stigma in people
with intellectual disabilities and courtesy stigma in family
carers: a systematic review. Res Dev Disabil. 2012;33:2122-40.
CrossRef
43. National Center for Learning Disabilities. Transitioning to life
after high school. Posted 2017 Jan 27. https://www.ncld.org/
research/state-of-learning-disabilities/transitioning-to-lifeafter-high-school/. Accessed February 11, 2020.
© 2020 Aurora Health Care, Inc.

Editorial

